Ken Griffin Neuro Pace Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuro Pace Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 8,400 shares of NPCE stock, worth $53,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,400
Previous 5,000
68.0%
Holding current value
$53,508
Previous $66,000
4.55%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
57Shares Held
19.8MCall Options Held
28.3KPut Options Held
300-
Kck Ltd. Tortola, D85.62MShares$35.8 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$21.7 Million0.62% of portfolio
-
Morgan Stanley New York, NY2.47MShares$15.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$15.5 Million1.86% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$7.29 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $158M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...